
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $65.5M | $76.1M | $95.8M | $119.1M | $119.8M | |
Revenue Growth (YoY) | -10.45% | 16.12% | 25.98% | 24.27% | 0.6% | |
Cost of Revenues | $27.4M | $29.5M | $33.3M | $33.5M | $37.7M | |
Gross Profit | $38.1M | $46.6M | $62.5M | $85.5M | $82.1M | |
Gross Profit Margin | 58.15% | 61.22% | 65.23% | 71.83% | 68.54% | |
R&D Expenses | $6M | $5.4M | $6.1M | $6.8M | $7.8M | |
Selling, General & Admin | $37.5M | $43.2M | $54.2M | $68.1M | $68.8M | |
Other Inc / (Exp) | $138K | $19M | $1.4M | -$1.8M | $8K | |
Operating Expenses | $53M | $59.5M | $73.8M | $88.5M | $92.8M | |
Operating Income | -$14.9M | -$13M | -$11.3M | -$3M | -$10.7M | |
Net Interest Expenses | $1.2M | $2M | $4.4M | $4.3M | $111K | |
EBT. Incl. Unusual Items | -$16M | $4M | -$14.4M | -$9.1M | -$10.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $337K | $802K | $112K | $109K | $933K | |
Net Income to Company | -$16.3M | $3.2M | -$14.5M | -$9.2M | -$11.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$16.3M | $3.2M | -$14.5M | -$9.2M | -$11.8M | |
Basic EPS (Cont. Ops) | -$1.03 | $0.17 | -$0.72 | -$0.42 | -$0.45 | |
Diluted EPS (Cont. Ops) | -$1.03 | $0.16 | -$0.72 | -$0.42 | -$0.45 | |
Weighted Average Basic Share | $15.9M | $19.3M | $20.1M | $22.1M | $26.1M | |
Weighted Average Diluted Share | $15.9M | $19.5M | $20.1M | $22.1M | $26.1M | |
EBITDA | $1.4M | $23.9M | $10.5M | $17.2M | $13.7M | |
EBIT | -$14.8M | $6M | -$9.9M | -$3.5M | -$9.8M | |
Revenue (Reported) | $65.5M | $76.1M | $95.8M | $119.1M | $119.8M | |
Operating Income (Reported) | -$14.9M | -$13M | -$11.3M | -$3M | -$10.7M | |
Operating Income (Adjusted) | -$14.8M | $6M | -$9.9M | -$3.5M | -$9.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $19.8M | $24.3M | $33.1M | $31.7M | $34.9M | |
Revenue Growth (YoY) | 4.51% | 22.88% | 35.88% | -4.27% | 10.12% | |
Cost of Revenues | $7.3M | $8.9M | $8.7M | $9M | $10.2M | |
Gross Profit | $12.5M | $15.5M | $24.4M | $22.6M | $24.6M | |
Gross Profit Margin | 63.09% | 63.55% | 73.8% | 71.42% | 70.6% | |
R&D Expenses | $1.1M | $1.8M | $2M | $1.8M | $2M | |
Selling, General & Admin | $10.1M | $12.4M | $17.2M | $17.8M | $20.3M | |
Other Inc / (Exp) | -- | $4K | $83K | $10K | $188K | |
Operating Expenses | $13.8M | $17.6M | $22.4M | $23M | $26.6M | |
Operating Income | -$1.3M | -$2.2M | $2M | -$441K | -$2M | |
Net Interest Expenses | $224K | $820K | $1.9M | -- | $280K | |
EBT. Incl. Unusual Items | -$1.5M | -$3M | $102K | -$275K | -$2.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $105K | $30K | -$237K | $33K | $291K | |
Net Income to Company | -$1.6M | -$3M | $339K | -$308K | -$2.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1.6M | -$3M | $339K | -$308K | -$2.4M | |
Basic EPS (Cont. Ops) | -$0.08 | -$0.15 | $0.02 | -$0.01 | -$0.09 | |
Diluted EPS (Cont. Ops) | -$0.08 | -$0.15 | $0.02 | -$0.01 | -$0.09 | |
Weighted Average Basic Share | $19M | $20M | $20.3M | $25.3M | $27M | |
Weighted Average Diluted Share | $19M | $20M | $21M | $25.3M | $27M | |
EBITDA | $3M | $3M | $7.5M | $5.1M | $4.7M | |
EBIT | -$1.3M | -$2.2M | $2.4M | -$95K | -$1.7M | |
Revenue (Reported) | $19.8M | $24.3M | $33.1M | $31.7M | $34.9M | |
Operating Income (Reported) | -$1.3M | -$2.2M | $2M | -$441K | -$2M | |
Operating Income (Adjusted) | -$1.3M | -$2.2M | $2.4M | -$95K | -$1.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $66.4M | $80.6M | $104.6M | $117.7M | $123M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $26.9M | $31.1M | $33.1M | $33.9M | $38.9M | |
Gross Profit | $39.5M | $49.5M | $71.4M | $83.7M | $84.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $5.9M | $6.1M | $6.3M | $6.6M | $8.1M | |
Selling, General & Admin | $38.7M | $45.4M | $59M | $68.7M | $71.3M | |
Other Inc / (Exp) | $4K | $19M | $1.5M | -$1.9M | $186K | |
Operating Expenses | $54.3M | $63.4M | $78.6M | $89.1M | $96.4M | |
Operating Income | -$14.8M | -$13.9M | -$7.2M | -$5.4M | -$12.3M | |
Net Interest Expenses | $901K | $2.6M | $5.6M | $2.2M | $547K | |
EBT. Incl. Unusual Items | -$15.7M | $2.5M | -$11.3M | -$9.5M | -$12.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $423K | $727K | -$155K | $379K | $1.2M | |
Net Income to Company | -$16.1M | $1.8M | -$11.1M | -$9.9M | -$13.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$16.1M | $1.8M | -$11.1M | -$9.9M | -$13.9M | |
Basic EPS (Cont. Ops) | -$1.00 | $0.11 | -$0.54 | -$0.44 | -$0.53 | |
Diluted EPS (Cont. Ops) | -$1.00 | $0.10 | -$0.54 | -$0.44 | -$0.53 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.9M | $23.9M | $15M | $14.8M | $13.3M | |
EBIT | -$14.7M | $5.1M | -$5.3M | -$6M | -$11.4M | |
Revenue (Reported) | $66.4M | $80.6M | $104.6M | $117.7M | $123M | |
Operating Income (Reported) | -$14.8M | -$13.9M | -$7.2M | -$5.4M | -$12.3M | |
Operating Income (Adjusted) | -$14.7M | $5.1M | -$5.3M | -$6M | -$11.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $19.8M | $24.3M | $33.1M | $31.7M | $34.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $7.3M | $8.9M | $8.7M | $9M | $10.2M | |
Gross Profit | $12.5M | $15.5M | $24.4M | $22.6M | $24.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $1.1M | $1.8M | $2M | $1.8M | $2M | |
Selling, General & Admin | $10.1M | $12.4M | $17.2M | $17.8M | $20.3M | |
Other Inc / (Exp) | -- | $4K | $83K | $10K | $188K | |
Operating Expenses | $13.8M | $17.6M | $22.4M | $23M | $26.6M | |
Operating Income | -$1.3M | -$2.2M | $2M | -$441K | -$2M | |
Net Interest Expenses | $224K | $820K | $1.9M | -- | $280K | |
EBT. Incl. Unusual Items | -$1.5M | -$3M | $102K | -$275K | -$2.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $105K | $30K | -$237K | $33K | $291K | |
Net Income to Company | -$1.6M | -$3M | $339K | -$308K | -$2.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$1.6M | -$3M | $339K | -$308K | -$2.4M | |
Basic EPS (Cont. Ops) | -$0.08 | -$0.15 | $0.02 | -$0.01 | -$0.09 | |
Diluted EPS (Cont. Ops) | -$0.08 | -$0.15 | $0.02 | -$0.01 | -$0.09 | |
Weighted Average Basic Share | $19M | $20M | $20.3M | $25.3M | $27M | |
Weighted Average Diluted Share | $19M | $20M | $21M | $25.3M | $27M | |
EBITDA | $3M | $3M | $7.5M | $5.1M | $4.7M | |
EBIT | -$1.3M | -$2.2M | $2.4M | -$95K | -$1.7M | |
Revenue (Reported) | $19.8M | $24.3M | $33.1M | $31.7M | $34.9M | |
Operating Income (Reported) | -$1.3M | -$2.2M | $2M | -$441K | -$2M | |
Operating Income (Adjusted) | -$1.3M | -$2.2M | $2.4M | -$95K | -$1.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $28.6M | $13.4M | $17M | $30.3M | $21.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.8M | $5.3M | $12.1M | $14.2M | $18.2M | |
Inventory | $449K | $246K | $251K | $155K | $195K | |
Prepaid Expenses | $2.9M | -- | -- | -- | -- | |
Other Current Assets | $2.9M | $13.5M | $10.3M | $3.5M | $4.9M | |
Total Current Assets | $356.8M | $249.8M | $243.3M | $267.2M | $237.3M | |
Property Plant And Equipment | $14.7M | $14.7M | $18.5M | $19.5M | $23.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $74M | $86M | $86M | $86M | $94.7M | |
Other Intangibles | $64.6M | $78.6M | $66.6M | $62.1M | $69.1M | |
Other Long-Term Assets | $4M | $4.1M | $5.5M | $9M | $11.8M | |
Total Assets | $514M | $433.2M | $419.9M | $443.9M | $436.6M | |
Accounts Payable | $1.3M | $565K | $2.2M | $2.6M | $1.4M | |
Accrued Expenses | $1.4M | $2.4M | $3.7M | $3.9M | $6.6M | |
Current Portion Of Long-Term Debt | $12.3M | $1.9M | $4.1M | $27K | $7M | |
Current Portion Of Capital Lease Obligations | $1.8M | $1.6M | $1.9M | $1.5M | $1.4M | |
Other Current Liabilities | $324.5M | $219M | $209M | $220M | $194.4M | |
Total Current Liabilities | $348.6M | $232.8M | $235.2M | $241.3M | $223.6M | |
Long-Term Debt | $12.2M | $33.1M | $30.8M | $4.3M | $5.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $368.3M | $275M | $274.8M | $252.2M | $239.3M | |
Common Stock | $193K | $204K | $206K | $254K | $267K | |
Other Common Equity Adj | $604K | -$99K | -$2.5M | -$1.1M | -$575K | |
Common Equity | $145.7M | $158.2M | $145.1M | $191.7M | $197.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $145.7M | $158.2M | $145.1M | $191.7M | $197.3M | |
Total Liabilities and Equity | $514M | $433.2M | $419.9M | $443.9M | $436.6M | |
Cash and Short Terms | $28.6M | $13.4M | $17M | $30.3M | $21.4M | |
Total Debt | $24.5M | $35M | $34.9M | $4.3M | $12.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $24.3M | $12.1M | $21.4M | $23.2M | $14.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $3.9M | $6.6M | $14.8M | $15.1M | $15.8M | |
Inventory | $349K | $286K | $218K | $205K | $220K | |
Prepaid Expenses | $3.4M | $10.6M | -- | -- | -- | |
Other Current Assets | -- | -- | $5.1M | $4.2M | $6M | |
Total Current Assets | $286.4M | $268.3M | $265M | $282.4M | $293.1M | |
Property Plant And Equipment | $15M | $14M | $18.5M | $20.5M | $25.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $74M | $86M | $86M | $86M | $94.7M | |
Other Intangibles | $61.6M | $77.2M | $63M | $71M | $73M | |
Other Long-Term Assets | $4.1M | $4.4M | $6.4M | $9.4M | $12.7M | |
Total Assets | $441.1M | $449.9M | $438.8M | $469.3M | $498.9M | |
Accounts Payable | $750K | $1.6M | $1.7M | $1.6M | $2.5M | |
Accrued Expenses | $1.1M | $3M | $5M | $7.2M | $6.1M | |
Current Portion Of Long-Term Debt | $11.9M | $1.8M | $5.4M | $23K | $7.9M | |
Current Portion Of Capital Lease Obligations | $2M | $1.4M | $1.7M | $1.5M | $1.4M | |
Other Current Liabilities | $258.1M | $240.3M | $228.3M | $241.1M | $258.6M | |
Total Current Liabilities | $279M | $252.4M | $250.8M | $258.4M | $284.1M | |
Long-Term Debt | $10.7M | $34M | $30.5M | $5.3M | $6.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $296.5M | $295M | $289.6M | $271.7M | $301.3M | |
Common Stock | $194K | $205K | $210K | $258K | $271K | |
Other Common Equity Adj | $465K | -$1.2M | -$2M | -$1.4M | -$133K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $144.7M | $154.9M | $149.2M | $197.7M | $197.7M | |
Total Liabilities and Equity | $441.1M | $449.9M | $438.8M | $469.3M | $498.9M | |
Cash and Short Terms | $24.3M | $12.1M | $21.4M | $23.2M | $14.1M | |
Total Debt | $22.6M | $35.8M | $35.9M | $5.3M | $14.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$16.3M | $3.2M | -$14.5M | -$9.2M | -$11.8M | |
Depreciation & Amoritzation | $16.2M | $17.8M | $20.4M | $20.6M | $23.5M | |
Stock-Based Compensation | $2.4M | $3M | $3.2M | $5.4M | $6.4M | |
Change in Accounts Receivable | $528K | -$1.3M | -$7.6M | -$4.1M | -$4M | |
Change in Inventories | $150K | $142K | -$14K | $97K | -$41K | |
Cash From Operations | $2.2M | $1.4M | $13.7M | $18.9M | $9.4M | |
Capital Expenditures | $16.8M | $29.8M | $8.8M | $16.3M | $24.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$19.4M | -$37M | -$36M | -$29.5M | -$19.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $8.9M | $29.4M | -- | -- | $5M | |
Long-Term Debt Repaid | -$12.2M | -$14.7M | -$1.7M | -$35.6M | -$420K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $190.1M | -$106.1M | -$11.2M | $13M | -$28M | |
Cash From Financing | $208.1M | -$90.7M | -$12.4M | $24.2M | -$22M | |
Beginning Cash (CF) | $134.1M | $325M | $198.7M | $164M | $177.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $190.9M | -$126.2M | -$34.7M | $13.6M | -$31.9M | |
Ending Cash (CF) | $325M | $198.7M | $164M | $177.6M | $145.7M | |
Levered Free Cash Flow | -$14.5M | -$28.4M | $4.8M | $2.6M | -$14.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.6M | -$3M | $339K | -$308K | -$2.4M | |
Depreciation & Amoritzation | $4.3M | $5.2M | $5.1M | $5.2M | $6.3M | |
Stock-Based Compensation | $626K | $729K | $1.3M | $1.9M | $1.9M | |
Change in Accounts Receivable | -$947K | -$1.3M | -$3.3M | -$919K | $2.3M | |
Change in Inventories | $46K | -$40K | $33K | -$50K | -$24K | |
Cash From Operations | -$1.4M | $2.5M | $4.6M | -$3.9M | $2M | |
Capital Expenditures | $1.3M | $2.7M | $1.9M | $3.4M | $9.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $645K | -$6.7M | -$6.6M | -$4.5M | -$12.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$2.2M | -- | -$232K | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$66.3M | $21.3M | $19.4M | $20.9M | $63.5M | |
Cash From Financing | -$68.4M | $21.3M | $21.1M | $21.1M | $63.9M | |
Beginning Cash (CF) | $325M | $198.7M | $164M | $177.6M | $145.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$69.1M | $17.1M | $19.1M | $12.6M | $53.3M | |
Ending Cash (CF) | $255.9M | $215.9M | $183.1M | $190.2M | $199M | |
Levered Free Cash Flow | -$2.6M | -$186K | $2.7M | -$7.3M | -$7.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$16.1M | $1.8M | -$11.1M | -$9.9M | -$13.9M | |
Depreciation & Amoritzation | $16.6M | $18.7M | $20.3M | $20.7M | $24.7M | |
Stock-Based Compensation | $2.6M | $3.1M | $3.8M | $6M | $6.4M | |
Change in Accounts Receivable | -$1.2M | -$1.6M | -$9.7M | -$1.8M | -$818K | |
Change in Inventories | $112K | $56K | $59K | $14K | -$15K | |
Cash From Operations | $4.3M | $5.3M | $15.7M | $10.4M | $15.3M | |
Capital Expenditures | $15.2M | $31.2M | $8M | $17.8M | $30.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$43.6M | -$44.3M | -$35.9M | -$27.4M | -$27.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$12.6M | -$12.5M | -$1.9M | -$35.4M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $151.5M | -$18.5M | -$13.1M | $14.5M | $14.6M | |
Cash From Financing | $169.1M | -$939K | -$12.5M | $24.1M | $20.8M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $129.8M | -$40M | -$32.7M | $7.1M | $8.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$10.9M | -$26M | $7.7M | -$7.4M | -$14.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1.6M | -$3M | $339K | -$308K | -$2.4M | |
Depreciation & Amoritzation | $4.3M | $5.2M | $5.1M | $5.2M | $6.3M | |
Stock-Based Compensation | $626K | $729K | $1.3M | $1.9M | $1.9M | |
Change in Accounts Receivable | -$947K | -$1.3M | -$3.3M | -$919K | $2.3M | |
Change in Inventories | $46K | -$40K | $33K | -$50K | -$24K | |
Cash From Operations | -$1.4M | $2.5M | $4.6M | -$3.9M | $2M | |
Capital Expenditures | $1.3M | $2.7M | $1.9M | $3.4M | $9.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $645K | -$6.7M | -$6.6M | -$4.5M | -$12.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$2.2M | -- | -$232K | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$66.3M | $21.3M | $19.4M | $20.9M | $63.5M | |
Cash From Financing | -$68.4M | $21.3M | $21.1M | $21.1M | $63.9M | |
Beginning Cash (CF) | $325M | $198.7M | $164M | $177.6M | $145.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$69.1M | $17.1M | $19.1M | $12.6M | $53.3M | |
Ending Cash (CF) | $255.9M | $215.9M | $183.1M | $190.2M | $199M | |
Levered Free Cash Flow | -$2.6M | -$186K | $2.7M | -$7.3M | -$7.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.